IQInvest research note
26 SEP 2026 · 00:44 ET
ABT
Abbott Laboratories
$101.29
$0.22 (+0.22%)up 0.22%
26 September 2026 · delayed 15+ min
F
Cut-offs are the grader's own: 97+ for an A+, below 60 is an F.
Abbott Laboratories earns a F on good profit margins (>10%) and positive free cash flow but high debt-to-equity ratio (>2.0) and negative earnings growth. Consider alternatives with better risk/reward profiles.
Adjusted for Moderate investors, Medium-term investors 4.0% suggested allocation Change these
IQ-ABT-20260926engine v1 · 7-category weighted scorecard